Analysis of
MMP-2-735C/T
MMP-9-1562C/T
ethnicity
lung cancer
matrix metalloproteinases
polymorphism
rs2285053
rs3918242
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
24 Jun 2023
24 Jun 2023
Historique:
received:
09
05
2023
revised:
12
06
2023
accepted:
20
06
2023
medline:
17
7
2023
pubmed:
14
7
2023
entrez:
14
7
2023
Statut:
epublish
Résumé
Matrix metalloproteinase (MMP)-2 and -9 are gelatinases which are capable of degrading type IV collagen and have been linked to cancer invasion and metastatic development. MMP-2 and MMP-9 gene polymorphisms may affect their biological function, and thus their role in cancer development and progression. We analyzed the association of the polymorphism frequencies of
Identifiants
pubmed: 37445754
pii: ijms241310576
doi: 10.3390/ijms241310576
pmc: PMC10341518
pii:
doi:
Substances chimiques
Matrix Metalloproteinase 9
EC 3.4.24.35
Matrix Metalloproteinase 2
EC 3.4.24.24
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Wroclaw Medical University
ID : SUBK.D010.22.041
Références
J Thorac Dis. 2020 Mar;12(3):349-362
pubmed: 32274101
Biomolecules. 2021 Aug 13;11(8):
pubmed: 34439874
Int J Cancer. 2015 Nov 15;137(10):2332-42
pubmed: 25975224
J Surg Res. 2013 Aug;183(2):517-23
pubmed: 23465389
Sci Rep. 2015 Jul 22;5:10056
pubmed: 26198673
Pharmacol Ther. 2021 Sep;225:107839
pubmed: 33774068
Proc Natl Acad Sci U S A. 1962 Jun 15;48:1014-22
pubmed: 13902219
Clin Chim Acta. 1998 Aug 28;276(2):173-7
pubmed: 9764735
Adv Pharmacol. 2018;81:241-330
pubmed: 29310800
Adv Med Sci. 2013;58(1):73-82
pubmed: 23640949
Cancer Genomics Proteomics. 2019 Jul-Aug;16(4):287-292
pubmed: 31243109
Int J Oncol. 2019 Jan;54(1):41-52
pubmed: 30365116
Tumour Biol. 2012 Dec;33(6):1819-28
pubmed: 22718017
Med Sci Monit. 2015 Dec 01;21:3740-7
pubmed: 26624903
Anticancer Res. 2023 Jan;43(1):343-349
pubmed: 36585186
JAMA. 1991 Aug 7;266(5):681-7
pubmed: 2072479
Anticancer Res. 2022 Nov;42(11):5335-5342
pubmed: 36288896
Lancet Oncol. 2002 Aug;3(8):461-9
pubmed: 12147432
Carcinogenesis. 2005 Jun;26(6):1117-21
pubmed: 15731163
Carcinogenesis. 2007 Mar;28(3):507-18
pubmed: 17183062
Lung Cancer. 2007 May;56(2):273-80
pubmed: 17208328
Prog Mol Biol Transl Sci. 2017;147:1-73
pubmed: 28413025
Ann Transl Med. 2016 Apr;4(8):150
pubmed: 27195268
Biomolecules. 2019 Mar 18;9(3):
pubmed: 30889876
Genet Test Mol Biomarkers. 2009 Oct;13(5):671-8
pubmed: 19814619
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Int J Mol Sci. 2020 Jun 27;21(13):
pubmed: 32604993
J Thorac Dis. 2017 Dec;9(12):5306-5313
pubmed: 29312740
Carcinogenesis. 2004 Feb;25(2):229-35
pubmed: 14604894
Oncogene. 2013 Jan 17;32(3):327-40
pubmed: 22349830
Oncotarget. 2017 Aug 11;8(46):80560-80567
pubmed: 29113325
Asian Pac J Cancer Prev. 2012;13(6):2853-6
pubmed: 22938472
Oncol Rep. 2007 Jan;17(1):217-23
pubmed: 17143501
Nat Rev Mol Cell Biol. 2007 Mar;8(3):221-33
pubmed: 17318226
Evid Based Complement Alternat Med. 2022 Sep 27;2022:7357160
pubmed: 36204131
Chin J Physiol. 2019 Sep-Oct;62(5):210-216
pubmed: 31670285
Medicine (Baltimore). 2018 Aug;97(35):e11859
pubmed: 30170377
Lung Cancer. 2002 Sep;37(3):241-56
pubmed: 12234692
BMC Cancer. 2017 Dec 05;17(1):823
pubmed: 29207990
Cancer Res. 2016 Jul 1;76(13):3676-83
pubmed: 27216194
Clin Cancer Res. 2005 Aug 1;11(15):5433-9
pubmed: 16061858
Anticancer Res. 2020 Jul;40(7):3619-3631
pubmed: 32620601
Lancet. 2017 Jan 21;389(10066):299-311
pubmed: 27574741
Anticancer Res. 2010 Apr;30(4):1195-9
pubmed: 20530427
BMC Cancer. 2012 Mar 28;12:121
pubmed: 22455335
Clin Cancer Res. 2001 Jan;7(1):5-22
pubmed: 11205917